0001096906-20-000150.txt : 20201103 0001096906-20-000150.hdr.sgml : 20201103 20201103172716 ACCESSION NUMBER: 0001096906-20-000150 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201103 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 201284478 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utmd-20201103.htm UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing
0000706698 false 0000706698 2020-11-03 2020-11-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported):  November 3, 2020

 

 

UTAH MEDICAL PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

Utah

 

000-12575

 

87-0342734

(State or other jurisdiction of

 

(Commission File Number)

 

(IRS Employer

incorporation or organization)

 

 

 

Identification No.)

 

 

 

 

 

7043 South 300 West

 

 

Midvale, Utah

 

84047

(Address of principal executive offices)

 

(Zip code)

 

 

 

Registrant’s telephone number, including area code:  

 

Phone: (801) 566-1200

 

 

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

ITEM 8.01—OTHER EVENTS

 

On November 3, 2020, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend.  A dividend of $.285 per share is payable on January 5, 2021 to shareholders of record at the close of business on December 15, 2020.  A copy of the press release is attached hereto as Exhibit 99.1

 

 

ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS

 

The following is filed as an exhibit to this report:  

 

Exhibit

Number*

 

 

Title of Document

 

 

Location

Item 99.1

 

Press release issued November 3, 2020: Utah Medical Products Inc. Increases Quarterly Dividend

 

 

 

 

 

 

This filing

 

 

 

 

 

_______________________________________

*All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

UTAH MEDICAL PRODUCTS, INC.

 

 

 

 

 

 

Dated: November 3, 2020

By:

/s/ Kevin L. Cornwell

 

 

Kevin L. Cornwell, Chief Executive Officer

 EX-99.1 2 utmd_ex99z1.htm PRESS RELEASE

EXHIBIT 99.1

 

Utah Medical Products, Inc. Increases Quarterly Dividend

 

Contact:  Crystal RiosNovember 3, 2020 

(801) 566-1200

 

Salt Lake City, Utah -Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on January 5, 2021 to shareholders of record at the close of business on December 15, 2020. This is about a 2% increase over the prior quarterly cash dividend.

 

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients.  For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.

 EX-101.DEF 3 utmd-20201103_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 utmd-20201103_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Amendment Description Shell Company Public Float Registrant CIK Small Business Well-known Seasoned Issuer Entity Address, Postal Zip Code Fiscal Year End Entity Address, City or Town City Area Code Entity Incorporation, State or Country Code Tax Identification Number (TIN) Ex Transition Period SEC Form Filer Category Trading Exchange Details Trading Symbol Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Voluntary filer Amendment Flag Local Phone Number Registrant Name Entity Address, State or Province Emerging Growth Company Number of common stock shares outstanding Soliciting Material Current with reporting Entity Address, Address Line One Period End date Entity File Number Interactive Data Current EX-101.PRE 5 utmd-20201103_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 6 utmd-20201103.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink XML 7 utmd-20201103_htm.xml IDEA: XBRL DOCUMENT 0000706698 2020-11-03 2020-11-03 0000706698 false 8-K 2020-11-03 UTAH MEDICAL PRODUCTS, INC. UT 000-12575 87-0342734 7043 South 300 West Midvale UT 84047 801 566-1200 false false false false false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information
Nov. 03, 2020
Details  
Registrant CIK 0000706698
Registrant Name UTAH MEDICAL PRODUCTS, INC.
SEC Form 8-K
Period End date Nov. 03, 2020
Tax Identification Number (TIN) 87-0342734
Emerging Growth Company false
Entity Incorporation, State or Country Code UT
Entity File Number 000-12575
Entity Address, Address Line One 7043 South 300 West
Entity Address, City or Town Midvale
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84047
City Area Code 801
Local Phone Number 566-1200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

+8U$<.&7J/P$ #P" / " ?@. M !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " !GBV-1)!Z;HJT #X 0 M&@ @ %D$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"% ,4 " !GBV-199!YDAD! #/ P $P @ %)$0 I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" "3$@ ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports utmd-20201103.htm utmd-20201103.xsd utmd-20201103_def.xml utmd-20201103_lab.xml utmd-20201103_pre.xml utmd_ex99z1.htm http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "utmd-20201103.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "utmd-20201103_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "utmd-20201103.htm" ] }, "labelLink": { "local": [ "utmd-20201103_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "utmd-20201103_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "utmd-20201103.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 34, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "fil", "nsuri": "http://utahmed.com/20201103", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "utmd-20201103.htm", "contextRef": "D201103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010 - Document - Document and Entity Information", "role": "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "utmd-20201103.htm", "contextRef": "D201103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Fiscal Year End" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Period End date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "SEC Form" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Registrant CIK" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Number of common stock shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Current with reporting" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Tax Identification Number (TIN)" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Voluntary filer" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Trading Exchange" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://utahmed.com/20201103/role/idr_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Details" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r4": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r5": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 15 0001096906-20-000150-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-20-000150-xbrl.zip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end